Avant Diagnostics Inc fka ADVX

[General_Sevier]

Has tiny impact. All current shareholders will only own 3.5% of the reverse merger company, if the reverse merger even happens.

Even after this, the reverse merger company is valued at todays price at over $60 million and Avant values itself under $10 million and I think it's less than $3 or $4 million.

All it means as other current OREO shareholders own a little more of the 3.5% than before. So the stock is less likely to fall as much as 95% in a heartbeat.